eCoin Peripheral Neurostimulator
BOSTON SCIENTIFIC CORPORATION · Decision date Mar 3, 2026
What did the FDA approve?
FDA records P200036/S010 as a supplement to PMA P200036, with the supplement type “Normal 180 Day Track No User Fee”. The recorded decision is approval, dated Mar 3, 2026.
FDA approval order statement
Approval for protocol revisions which clarified the definition of subject enrollment and updates to the Schedule of Activities table regarding follow-up phone calls and clarification of protocol-unrelated standards of clinical care.
- Regulatory pathway
- PMA supplement
- Supplement type
- Normal 180 Day Track No User Fee
- Clinical specialty
- Gastroenterology, Urology
- Decision date
- Mar 3, 2026
- FDA change category
- Postapproval Study Protocol
Regulatory record facts
- Identifier
- P200036/S010
- Regulatory pathway
- PMA supplement
- Applicant
- BOSTON SCIENTIFIC CORPORATION
- Product code
- QPT
- Decision code
- APPR
- Decision date
- Mar 3, 2026
- Source update
- Nov 9, 2026
- Original record
- Open FDA source record
About this medical device
FDA device category: Stimulator, tibial, electrical, implantable, for urinary incontinence.
- Applicant
- Boston Scientific Corporation
- Product code
- QPT
- FDA device class
- 3
For the original device and its historical approval scope, see PMA P200036. Subsequent supplements may change the device or its indications.
FDA decision timeline
P200036 · Original PMA
eCoin Peripheral Neurostimulator
P200036/S009 · Related supplement
eCoin Tibial Nerve Stimulator System
P200036/S010 received
Application receipt date recorded by FDA.
P200036/S010 · FDA decision
Normal 180 Day Track No User Fee
P200036/S011 · Related supplement
eCoin Peripheral Neurostimulator
P200036/S012 · Related supplement
eCoin Peripheral Neurostimulator
Timeline entries are records held by MedtechLedger for P200036. View FDA’s full supplement list.
Related devices and submissions
Same PMA: P200036
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
| BOSTON SCIENTIFIC CORPORATION | PMA approval | Mar 1, 2022 | FDA | |
eCoin Tibial Nerve Stimulator SystemP200036/S009 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Oct 2, 2025 | FDA |
eCoin Peripheral NeurostimulatorP200036/S011 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Jul 20, 2026 | FDA |
eCoin Peripheral NeurostimulatorP200036/S012 | BOSTON SCIENTIFIC CORPORATION | PMA supplement | Sep 9, 2026 | FDA |
Explore the linked device profile
Other records with product code QPT
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
AltavivaP240011/S016 | Medtronic Neuromodulation | PMA supplement | Sep 14, 2026 | FDA |
AltavivaP240011/S015 | Medtronic Neuromodulation | PMA supplement | Aug 14, 2026 | FDA |
AltavivaP240011/S010 | Medtronic Neuromodulation | PMA supplement | Jul 13, 2026 | FDA |
AltavivaP240011/S014 | Medtronic Neuromodulation | PMA supplement | Jun 16, 2026 | FDA |
AltavivaP240011/S013 | Medtronic Neuromodulation | PMA supplement | May 13, 2026 | FDA |
A shared product code identifies a classification relationship; it does not establish clinical equivalence.
Regulatory context
A PMA supplement records a change to a device with an existing premarket approval. The supplement’s approval applies to the change described in that submission.
Read our guide to FDA clearance and approval · FDA’s explanation of this pathway
Manufacturer intelligence
Boston Scientific Corporation
- Headquarters
- Not reported
- Brand website
- bostonscientific.com
- FDA applicant address
- 100 Boston Scientific Way, Marlborough, MA, 01752
Sources and methodology
- Original FDA record: P200036/S010
- openFDA source data · Source release Nov 9, 2026 · Retrieved Nov 20, 2026
FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.
How we use FDA records




